Pelvic floor disorders share underlying genetic architecture across seemingly distinct conditions, revealing therapeutic targets that could address multiple disorders simultaneously. This finding shifts treatment from symptom-specific interventions to mechanistic approaches targeting shared pathways.
Key Points
- Pelvic floor disorders share common genetic risk factors across conditions
- Network analysis identifies therapeutic targets applicable to multiple disorders
- Genetic architecture suggests unified rather than isolated disease mechanisms
Longevity Analysis
Pelvic floor dysfunction directly impairs quality of life, continence, sexual function, and structural integrity in aging populations. Understanding the shared genetic basis permits intervention at the mechanistic level rather than treating isolated symptoms—a critical distinction for sustained improvement. This approach recognizes that restoration of pelvic floor function supports broader structural integrity, nervous system signaling through pelvic organs, and hormonal regulation in ways that isolated symptom management cannot address.
Original published by Nature - npj Aging, by Jiawen Wang.